Yoshimura A, Yamada T, Serizawa M, Uehara H, et al. High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinib. Cancer Sci 2023;114:606-618.
PMID: 36169649